Alumis (ALMS) Net Income towards Common Stockholders (2023 - 2025)

Alumis' (ALMS) quarterly Net Income towards Common Stockholders came in at -$92.9 million in Q4 2025, down 181.75% year-on-year from $113.6 million in Q4 2024, and up 16.13% on a QoQ basis from -$110.8 million in Q3 2025.

Alumis (ALMS) Net Income towards Common Stockholders (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Net Income towards Common Stockholders data on file, last reported at -$92.9 million in Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 181.75% year-over-year to -$92.9 million in Q4 2025; TTM through Dec 2025 was -$250.9 million, a 8.38% decrease from a year earlier, with the FY2025 full-year figure at -$243.3 million, down 4.66% from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 stood at -$92.9 million, up from -$110.8 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for ALMS reached as high as $59.3 million in Q2 2025 and fell as low as -$110.8 million in Q3 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$55.0 million across 3 years, with a median of -$48.9 million in 2024.
  • On a YoY basis, Net Income towards Common Stockholders climbed as much as 204.98% in 2025 and fell as far as 181.75% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$41.3 million in 2023, then increased by 20.16% to -$33.0 million in 2024, then sank by 181.75% to -$92.9 million in 2025.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$92.9 million in Q4 2025, -$110.8 million in Q3 2025, and $59.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -625.73
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -0.68
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 366.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Alumis 2.37 Bn 2.06 Bn - -92.89 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -92.89 Mn
Sep 30, 2025 -110.75 Mn
Jun 30, 2025 59.32 Mn
Mar 31, 2025 -106.62 Mn
Dec 31, 2024 -32.97 Mn
Sep 30, 2024 -93.12 Mn
Jun 30, 2024 -56.51 Mn
Mar 31, 2024 -48.94 Mn
Dec 31, 2023 -41.30 Mn
Sep 30, 2023 -44.56 Mn
Jun 30, 2023 -36.71 Mn